Healthcare use among persons with visual impairment: Difference-in-difference estimations.

BACKGROUND Studies on healthcare service use among persons with visual impairments in countries with different healthcare systems are needed for drawing global inferences. OBJECTIVE The goal was to assess the impact of visual impairment on healthcare service use. METHODS A retrospective cohort study on health insurance claims data from the National Health Insurance System (NHIS) was conducted. All data from 2002 to 2013 for 2206 and 8824 persons with and without visual impairments, respectively, were extracted and aggregated monthly, generating a total of 162,876 and 568,459 person-month observations, respectively. The dependent variable was total expenditures. Difference-in-difference estimations based on a multivariate log-normal random-effect regression were employed. RESULTS Persons with visual impairments spent 5.7% and 6.8% more on total healthcare expenditures per month and outpatient healthcare expenditures, respectively, than those without visual impairments, after adjusting for pre-impairment differences. Further results revealed an upward trend in expenditures, particularly among those with visual impairments; this increase was the highest during the year prior impairment (approximately 32% and 21% more for total and outpatient services, respectively, compared with baseline). Inpatient healthcare expenditures showed a similar increase (by approximately 26%) during the year prior impairment compared with baseline; however, the magnitude dropped to approximately 14% and 6% during the 1st and 2nd years of impairment, respectively. Conversely, the annual pattern of expenditure increase was parallel over time for persons without visual impairments, regardless of service. CONCLUSION Our findings suggest a need for health management and effective care use, particularly the year prior to visual impairment onset.

[1]  Orley Ashenfelter,et al.  Using the Longitudinal Structure of Earnings to Estimate the Effect of Training Programs , 1984 .

[2]  Rajeev Dehejia,et al.  Propensity Score-Matching Methods for Nonexperimental Causal Studies , 2002, Review of Economics and Statistics.

[3]  William H Morgan,et al.  Mortality and hospital morbidity of working-age blind , 2013, British Journal of Ophthalmology.

[4]  Richard J Willke,et al.  Association between vision loss and higher medical care costs in Medicare beneficiaries costs are greater for those with progressive vision loss. , 2007, Ophthalmology.

[5]  Robert P Finger,et al.  The economic burden of visual impairment and blindness: a systematic review , 2013, BMJ Open.

[6]  M. Essink‐bot,et al.  A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group. , 2000, American journal of public health.

[7]  S. Kang,et al.  Visual Impairment of Korean Population: Prevalence and Impact on Mental Health. , 2015, Investigative ophthalmology & visual science.

[8]  이승규,et al.  Prevalence and risk factors of visual impairment and blindness in Korea: The Fourth Korea National Health and Nutrition Examination Survey in 2008-2010 , 2014 .

[9]  T. Rim,et al.  Prevalence and risk factors of visual impairment and blindness in Korea: the Fourth Korea National Health and Nutrition Examination Survey in 2008–2010 , 2014, Acta ophthalmologica.

[10]  P. Chiang,et al.  The impact of vision impairment on vision-specific quality of life in Germany. , 2011, Investigative ophthalmology & visual science.

[11]  D. Pascolini,et al.  Global estimates of visual impairment: 2010 , 2011, British Journal of Ophthalmology.

[12]  R. Bourne,et al.  The Economic Impact of Blindness in Europe , 2017, Ophthalmic epidemiology.

[13]  Tien Yin Wong,et al.  Visual impairment, causes of vision loss, and falls: the singapore malay eye study. , 2008, Investigative ophthalmology & visual science.

[14]  Soyeon Ahn,et al.  Burden of Visual Impairment and Chronic Diseases. , 2016, JAMA ophthalmology.

[15]  L. Iezzoni,et al.  Health Care for Americans with Disabilities--25 Years after the ADA. , 2015, The New England journal of medicine.

[16]  E. Lee,et al.  Incremental impact of body mass status with modifiable unhealthy lifestyle behaviors on pharmaceutical expenditure. , 2016, Research in social & administrative pharmacy : RSAP.

[17]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[18]  Bernadette A. Thomas,et al.  Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[19]  H. Taylor,et al.  Global burden of disease and visual impairment , 2006, The Lancet.

[20]  Emily W. Gower,et al.  Economic impact of visual impairment and blindness in the United States. , 2007, Archives of ophthalmology.

[21]  C. Weeraratne,et al.  Challenges faced by visually disabled people in use of medicines, self-adopted coping strategies and medicine-related mishaps , 2012, WHO South-East Asia journal of public health.

[22]  J. Semmens,et al.  Health Service Use and Mortality of the Elderly Blind. , 2015, Ophthalmology.

[23]  H. Choi,et al.  Visual impairment and risk of depression: A longitudinal follow-up study using a national sample cohort , 2018, Scientific Reports.

[24]  P. Mitchell,et al.  Visual impairment and subsequent use of support services among older people: longitudinal findings from the Blue Mountains Eye Study. , 2013, American journal of ophthalmology.

[25]  J E Keeffe,et al.  Impact of unilateral and bilateral vision loss on quality of life , 2005, British Journal of Ophthalmology.

[26]  J. Doyle,et al.  Direct costs of blindness experienced by patients enrolled in managed care. , 2008, Ophthalmology.

[27]  T. Wong,et al.  Health burden associated with visual impairment in Singapore: the Singapore epidemiology of eye disease study. , 2014, Ophthalmology.

[28]  T. Bailey,et al.  Identifying solutions to medication adherence in the visually impaired elderly. , 2014, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.

[29]  J. Oh,et al.  Qualitative Study for Medication Use among Visually Impaired in Korea , 2016 .

[30]  M. Dempster,et al.  Help needed in medication self-management for people with visual impairment: case-control study. , 2012, The British journal of general practice : the journal of the Royal College of General Practitioners.